氯胺酮、芬太尼等联合用于人流镇痛的研究

Study of Using Ketalar Fentanyl Atropin Diprivan Intravenous Injection For Analgesia of Artificial Abortion

目的 探讨氯胺酮—芬太尼—阿托品—得普利麻(KFAD)联合使用对人工流产镇痛效果以及手术的影响。方法 对100例要求人工流产者给予KFAD联合静脉用药,实施无痛人流(研究组)。对照组100例仅给予静脉推注生理盐水。观察镇痛效果,手术时间,出血量,药物毒副作用。结果 两组人工流产者镇痛效果比较差异极为显著(P<0.01),无痛人流者手术时间缩短,人流综合征发生率减少,失血量无显著差异(P>0.05)。结论 KFAD联合用于人流镇痛效果良好,是安全,有效的人流镇痛方法。

Objectives To investigate the effect of the injection intravenous of Ketalar-Fentanyl-Atropin-Dirivan(KFAD) for analgesia of artificial abortion. Methods A total of 100 cases of patients who demanded artificial abortion were provided with KFAD iv. (obser va-tion group); Another 100 cases were iv N. S only (control group). Observing and recording the effect of analgesia of operation, duration of operation, volume of hemorrhage and side effect. Results Observation group: the total analgesia effective rate was 96 cases. The median of operation time was 3min 50 and the mean of hemorrhage was 28. 55ml The incidence of artificial a-bortion syndrome was 3%. And that was respectively 0, 5. Omin, 29. 30ml,11% of. There was significant difference of analgesia and incidence of artificial abortion syndrome in both group. The time of operation and hemorhage were no diference. Conclusions KFAD intravenous injection for analgesia of artifical abortion is a safe, effective and no obvious side effects. The analgesic effect is very good, and can reduce the incidence of the artifical abortion syndrome.